tirzepatide weight loss vs semaglutide efficacy versus Once Weekly in Patients with Type 2 Diabetes 💉 Semaglutide vs. Tirzepatide —

Zepbound Tirzepatide Injection Syringes, 15 mg/0.5 mL is a prescription medication used for the treatment of type 2 diabetes in adults

May Reduce Risk of Heart Attack & Stroke Early research suggests that Tirzepatide could play a role in reducing the incidence of major cardiovascular events like heart attacks and strokes

It is meant to be used alongside a reduced-calorie diet and increased physical activity, not as a standalone fix

At 72 weeks, participants receiving Tirzepatide 5mg, 10mg, or 15mg achieved mean weight reductions of 15.0%, 19.5%, and 20.9% respectively, compared to 3.1% with placebo

Mounjaro FDA-approved for type 2 diabetes (2022)

These medications have incredible potential for weight loss and blood sugar management